Abstract − The purification of the MeOH extract from Impatiens basamina by repeated column chromatography led to the isolation of one new tetrahydronaphthalene (1), together with eleven known compounds (2 -12). The structure of the new compound (1) was determined by spectral data analysis ( 
Introduction
Impatiens balsamina (Balsaminaceae), also known as Garden balsam, is widely distributed in Korea, China and India. I. balsamina has been used as Chinese medicine to treat anti-cancer and anti-inflammatory herb, also has been used as a Korean traditional medicine for the treatment of scrofulosis, carbuncle, and dysentery.
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Previous phytochemical investigations on I. balsamina reported the isolation of triterpenoid saponins, quinones, coumarin, flavonoids, and phenolic compounds, and there were several reports on various biological activities.
4-10
Our earlier phytochemical investigation on white petal of I. balsamina resulted in the isolation of antineurodegenerative biflavonoid glycosides and antiinflammatory phenolic compounds. 9, 10 In a continuing search for bioactive constituents from Korean medical plant sources, we investigated the MeOH extract of stems of I. balsamina. The purification of hexane and EtOAc fractions by repeated column chromatography led to the isolation of one new tetrahydronaphthalene (1), together with eleven known compounds (2 -12) . The structure of 1 was established on spectral data analysis ( 
Experimental
General experimental procedures -Optical rotations were measured on a Jasco P-2000 polarimeter using methanol solvent. Ultraviolet (UV) spectra were recorded with a Shimadzu UV-1601 UV-vis spectrometer. High Resolution ESI Mass Spectrometer data were obtained with a Waters SYNAPT G2 mass spectrometer. Infrared (IR) spectra were recorded on a Bruker IFS-66/S Fouriertransform IR spectrometer. NMR spectra were recorded on Varian UNITY INOVA 500 NMR spectrometer at 500 MHz ( Extraction and isolation -The dried stems of I. balsamina (2 kg) were extracted with 80% MeOH at room temperature. The filtrate was evaporated in vacuo to yield MeOH extract (294 g), which was suspended in distilled H 2 O (2.4 L) and then successively partitioned with hexane, CHCl 3 , EtOAc and n-BuOH, yielding 20, 11, 6, and 28 g, respectively. The EtOAc fraction (5 g) was separated over a silica gel column with a solvent system of CHCl 3 / MeOH/water (7:1:0.1) to yielded five sub-fractions (E1-E5). Sub-fraction E1 (1.8 g) was chromatographed on a RP-C 18 silica gel column with 30% aqueous MeOH to yield nine sub-fractions (E11-E19). Fraction E12 (430 mg) was purified by RP-C 18 semi-prep. HPLC (30% MeOH) to yield 2 (9 mg, t R = 17.1 min). Fraction E2 (1.1 g) was separated by RP-C 18 silica gel column with 30% aqueous MeOH to give nine sub-fractions (E21-E29). Sub-fraction E23 (161 mg) was purified using RP-C 18 semi-prep. HPLC (30% MeOH) to yield 1 (20 mg, t R = 15.1 min), 6 (24 mg, t R = 21.1 min), and 3 (7 mg, t R = 22.4 min). E3 (557 mg) was subjected to RP-C 18 silica gel column with 45% aqueous MeOH to give five sub-fractions (E31-E35). Fraction E31 (148 mg) was purified by RP-C 18 semi-prep. HPLC (30% CH 3 CN) to yield 4 (100 mg, t R = 11.1 min). Fraction E5 (235 mg) was purified using RP-C 18 semi-prep. HPLC (20% CH 3 CN) to yield 5 (32 mg, t R = 21.2 min). The hexane soluble fraction was chromatographed on a silica gel column with hexane/EtOAc (20:1 to 1:1) to give eight sub-fractions (H1-H8). Fraction H2 (546 mg) was subjected to using a RP-C 18 silica gel column with 95% aqueous MeOH to yield 11 (9 mg, t R = 34.4 min). Fraction H3 (918 mg) was separated to RP-C 18 silica gel column with 90% aqueous MeOH to yield eight sub-fractions (H31-H38). Subfraction H32 (85 mg) was purified using RP-C 18 semi-prep. HPLC (90% MeOH) to yield 7 (9 mg, t R = 36.9 min). Fraction H36 (117 mg) was purified by semi-prep. HPLC (CHCl 3 / MeOH 120:1) to give 12 (88 mg, t R = 11.0 min). Fraction H5 (2.4 g) was chromatographed on a RP-C 18 silica gel column (95% aqueous MeOH) to give twelve sub-fractions (H51-H512). Subfraction H56 (89 mg) was purified using RP-C 18 semi-prep. HPLC (95% MeOH) to yield 8 (4 mg, t R = 17.8 min). Fraction H57 (169 mg) was purified by semi-prep. HPLC (hexane/EtOAc 3:1) to yield 9 (3 mg, t R = 15.3 min). Fraction H512 (112 mg) was purified using semi-prep. HPLC (hexane/EtOAc 3:1) to give 10 (7 mg, t R = 8.8 min).
1β,2α,4β-Triol-1,2,3,4-tetrahydronaphthalene (1) Measurement of NO Production and Cell Viability − Murine microglial BV-2 cells were plated into a 96-well plate (3 × 10 4 cells/well). After 24 h, cells were pretreated with samples for 30 min and then stimulated with 100 ng/ mL of LPS for another 24 h. Nitrite, a soluble oxidation product of NO, was measured in culture media using the Griess reaction. The supernatant (50 μL) was harvested and mixed with an equal volume of Griess reagent (1% sulfanilamide, 0.1% N-1-naphthylethylenediamine dihydrochloride in 5% phosphoric acid). After 10 min, the absorbance at 540 nm was measured using a microplate reader. Sodium nitrite was used as a standard to calculate the NO 2 -concentration. Cell viability was tested by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay. N G -Mono-methyl-L-arginine was evaluated as a positive control.
NGF and cell viability assays − C6 glioma cells were used to measure NGF release into the medium. C6 cells were purchased from the Korean Cell Line Bank and maintained in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin in a humidified incubator with 5% CO 2 . C6 cells were seeded into 24-well plates (1 × 10 5 cells/well). After 24 h, the cells were treated with DMEM containing 2% FBS and 1% penicillin-streptomycin with 20 μM of each sample for one day. The cell viability of the C6 cells was tested via an MTT assay. 6-shogaol was evaluated as a positive control.
Result and Discussion
The structures of compounds 2 -12 were determined by comparison of their spectroscopic data with those in the literatures to be 1β,2β,4β-triol-1,2,3,4-tetrahydronaphthalene 
